Intertek Group PLC
10 April 2008
Stock Exchange Release
10 April 2008, 7am London, UK
Intertek acquires 4-Front Research
Intertek Group plc (Intertek), the leading provider of quality and safety
solutions to a wide range of industries around the world, announces the
acquisition of 4-Front Research Limited, 4-Front Research UK Limited, 4 Front
Research SAS (France) and Four Front Research (India) Pvt Limited), (together
'4-Front Research'), a provider of testing services for consumer healthcare and
related products.
Intertek purchased 4-Front Research from owner Jon Holt for an initial cash
consideration of GBP 6 million and an estimated deferred consideration of GBP
4.4 million payable in June 2009, and based on 2008 performance.
4-Front Research provides analytical support for clinical research studies on
cosmetic, personal care, functional food, and over-the-counter (OTC)
pharmaceutical and medical products. Customers, which include national and
international consumer product brands, use 4-Front Research's services for
product development, support, and to verify promotional statements. Products are
evaluated for dermatological, allergenic, sunlight or dental effects amongst
others.
With seven sites in England and sites in Hyderabad, India and Paris, France,
4-Front employs 110 people and will form part of Intertek's Consumer Goods
division.
Wolfhart Hauser, Chief Executive Officer of Intertek, commented:
'4-Front Research adds new high-value services to support our consumer
healthcare customers in helping them to develop and monitor products. The
acquisition also gives us a strategic position to support future and growing
demand for consumer healthcare products within India and other Asian markets
with its locations in India, supported by the European network.'
-ends-
Contacts
Aston Swift / Sarah Ogilvie Intertek
Telephone: +44 (0) 20 7396 3400
aston.swift@intertek.com / sarah.ogilvie@intertek.com
Richard Mountain / Sophie Kernon, Financial Dynamics
Telephone: +44 (0) 20 7269 7121
richard.mountain@fd.com / sophie.kernon@fd.com
Notes to Editors
ABOUT INTERTEK
Intertek (LSE: ITRK) is a leading provider of quality and safety solutions
serving a wide range of industries around the world. From auditing and
inspection, to testing, quality assurance and certification, Intertek people are
dedicated to adding value to customers' products and processes, supporting their
success in the global marketplace. Intertek has the expertise, resources and
global reach to support its customers through its network of more than 1,000
laboratories and offices and over 21,000 people in 110 countries around the world.
www.intertek.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.